Credits: Canva
In the 1970s, India faced nearly 200,000 polio cases each year. This was not unusual, before vaccines became widespread, diseases we now rarely think about, like polio, caused unnecessary death and immense suffering. Measles, for instance, claimed an estimated 2.6 million lives annually before its vaccine was introduced in the early 1960s.
To ensure every child benefits from vaccines and is protected from preventable diseases, we must learn from successful campaigns, including the global effort to eradicate polio.
Also Read: mRNA COVID Vaccines Found To Help Cancer Patients Live Longer: Can This Be The Ultimate Cancer Cure?
Since the global push to eliminate polio began in 1988, cases have dropped by 99.9%. India was officially declared polio-free on March 27, 2014, by the World Health Organization (WHO), following the last reported case of wild polio on January 13, 2011, and a subsequent three-year period without any new cases.
This marked one of the most formidable milestones in public health: India—and the entire South-East Asia Region was certified polio-free, despite limited resources and enormous challenges. On World Polio Day, we take a closer look at how the polio vaccine helped the world stop a global threat.
Poliomyelitis, or polio, is a viral disease that in its early stages can cause fatigue, headaches, stiffness, and limb pain after exposure to the poliovirus, according to the World Health Organization (WHO). About one in 200 infections leads to paralysis, and 5–10% of those paralyzed may die if the disease immobilizes their breathing muscles. While polio mainly affects children under five, anyone who is unvaccinated is at risk.
In the 19th and 20th centuries, frequent polio outbreaks made it one of the most feared diseases in the United States. The deadliest outbreak occurred in 1952, claiming more than 3,000 lives, according to US public health data.
Also Read: Not All Antidepressants Affect Your Body The Same; Here’s What You Need To Know About Side Effects
The United States faced its worst polio outbreak in 1952, with nearly 58,000 cases of paralysis and just over 3,000 deaths. Thanks to widespread vaccination, polio was eliminated in the country by 1979.
India launched the Pulse Polio Immunization Programme on 2 October 1994, at a time when the country accounted for nearly 60% of all polio cases worldwide. Two decades later, on 27 March 2014, India was officially declared polio-free by the World Health Organization, following the last reported case in Howrah, West Bengal, on 13 January 2011, according to WHO records.
The success of this campaign hinged on ensuring vaccines reached every child, including those in the most remote and vulnerable communities. Strong commitment at all levels, from policymakers and health authorities to frontline workers, partners, and community volunteers ensured that life-saving polio drops were delivered to children wherever they were, whether at home, in school, or while traveling.
About The Polio Vaccine
The first polio vaccine was developed in the early 1950s by Dr. Jonas Salk and approved for use across the United States in 1955. This injectable, inactivated polio vaccine (IPV) is still in use in some countries today.
In the late 1950s and early 1960s, Dr. Albert Sabin developed a second option: the oral polio vaccine (OPV). Introduced into the US immunization schedule in 1961, it was inexpensive and easy to administer, which helped it become the most widely used polio vaccine in national immunization programs around the world. While it’s no longer used in the US, it remains especially effective in developing countries.
The two main types of polio vaccines are:
Polio vaccines have played a key role in eliminating the wild form of the disease from many parts of the world, including the Americas, Europe, Southeast Asia, and Africa, according to the World Health Organization (WHO). Czechoslovakia was the first country to show that nationwide eradication of wild poliovirus was possible, achieving this in 1960 after a strong vaccination campaign in which roughly 93% of children received the oral polio vaccine.
Despite these successes, wild poliovirus remains endemic in a few regions, notably Afghanistan and Pakistan.
Credits: Canva
The State of Global Air 2025 report offers a worrying look at how the planet’s air quality is declining. It reveals that pollution has now become the second biggest cause of premature deaths worldwide, coming just after high blood pressure.
The report, prepared by the Health Effects Institute (HEI) in partnership with the University of Washington’s School of Medicine and the NCD Alliance in Geneva, draws attention to the sharp increase in pollution-linked diseases.
One of the most alarming findings is the growing connection between toxic air and dementia. This has raised a key question among people, can long-term exposure to polluted air actually trigger dementia? Here’s what experts and data reveal.
Over the past several days, Delhi and its neighbouring cities have been trapped under a thick layer of smog, with air quality swinging between “poor” and “very poor.” The situation worsened sharply after Diwali, when fireworks filled the air with dense smoke. Reports noted that this was Delhi’s worst post-Diwali air quality in four years.
Every winter, the city faces this predictable yet avoidable crisis. Dr Arjun Khanna, pulmonologist at Amrita Hospital, told us that his phone has been “ringing non-stop” since the Diwali weekend. “We are seeing a surge in patients with breathing difficulties and sore throats,” he said. “This year’s winter is expected to be harsher, which will make the air quality even worse. The volume of firecrackers has been overwhelming, the smog is already visible, and the weather feels heavy and dull.”
He warned that the coming weeks will be particularly tough for Delhi-NCR residents and urged people to take precautions seriously.
Air pollution is no longer limited to the lungs or heart as now, it is also being tied to neurological decline. According to the State of Global Air 2025 report, 626,000 deaths related to dementia in 2023 were linked to long-term exposure to air pollution. That means nearly 29% of all dementia deaths globally had an environmental cause. For the first time, the report also measured how much healthy life pollution costs humanity, 11.6 million years lost due to its contribution to dementia.
With more than one in four dementia deaths connected to polluted air, the report underlines a growing risk for ageing populations worldwide. Fine particulate matter, known as PM2.5, harms not just the respiratory and cardiovascular systems but also the brain.
The report explains that microscopic pollutants can travel from the lungs into the bloodstream and eventually reach the brain. Once there, these particles trigger inflammation and oxidative stress, leading to damage in brain cells and tissues. This accelerates neurodegeneration and increases the risk of Alzheimer’s disease, vascular dementia, and mild cognitive impairment, all conditions marked by memory loss and reduced thinking ability.
Researchers also found that air pollution can disrupt brain development in children and young adults, increasing the risk of autism, anxiety, and depression later in life.
While lifestyle factors such as smoking or poor diet remain major contributors to dementia, experts warn that pollution exposure is far more widespread affecting billions of people. Even a small rise in individual risk, therefore, results in a major global health burden.
The data from the report also reveal that pollution drives a wide range of non-communicable diseases (NCDs):
Overall, 95% of all air pollution deaths occurred among people over the age of 60, and 6.8 million deaths were due to NCDs.
India’s Supreme Court recently relaxed its blanket ban on firecrackers in New Delhi during Diwali, allowing limited use of “green crackers” which is a cleaner alternative designed to cut emissions by about 30%. The court permitted their use during specific hours, but as in past years, compliance was poor.
New Delhi and its wider metropolitan area is home to over 30 million people but still these cities remain among the most polluted regions on Earth, particularly during the winter. The combination of Diwali fireworks, low temperatures, and smoke from crop burning in nearby states consistently traps the city under layers of toxic haze.
Authorities have announced temporary measures such as restricting construction, banning diesel generators, and limiting vehicle movement. However, environmentalists stress that these are short-term fixes. Long-lasting change, they argue, requires cleaner energy policies, stricter emission standards, and greater public accountability to prevent this annual health emergency.
Credits: Canva
A two-year-old child from Meghalaya’s West Garo Hills district reportedly tested positive for polio in 2025, a highly contagious and potentially fatal disease that once crippled millions before being nearly wiped out by vaccines.
Officials from the Union Health Ministry confirmed that the infection was vaccine-derived, stressing that India’s polio-free status remains unaffected. But what exactly does “vaccine-derived” mean, and is it dangerous? Can such a case spread from one person to another? Let’s break it down.
A vaccine-derived poliovirus (VDPV) is a mutated form of the weakened live virus used in the oral polio vaccine (OPV). According to the Centers for Disease Control and Prevention (CDC), if this weakened strain continues to circulate among communities with poor vaccination coverage or replicates inside a person with a weak immune system, it can revert to a version capable of causing paralysis and illness.
Interestingly, the oral polio vaccine (OPV) has played a crucial role in eliminating wild poliovirus globally. It contains one or more weakened strains of the virus and is administered as oral drops, which help build immunity in the gut, stopping the virus from spreading. However, when too few people are vaccinated, the weakened virus can continue moving from person to person, mutating over time, and eventually regaining its disease-causing ability.
However, it is important to remember that polio drops are safe and have helped nearly every country eliminate the disease. Still, in extremely rare cases, especially among children with weak immune systems, the vaccine strain can cause infection.
There are two kinds of vaccines used to protect against polio, one given orally and the other through injection.
This is the most widely used vaccine in India. It contains a weakened version of the poliovirus that helps the body build immunity without causing illness. It is administered orally, usually as drops, and is used during mass campaigns such as National Immunization Days.
IPV, on the other hand, contains a killed version of the poliovirus and is given as an injection. It forms part of India’s routine immunization schedule and is often delivered in combination with other vaccines.
In India, both vaccines are used, though OPV remains preferred because it’s simple to administer during large-scale drives.
India’s last recorded wild poliovirus case occurred years ago, but in 2024, a two-year-old child in Meghalaya was confirmed to have vaccine-derived polio. Officials clarified that this does not affect the country’s polio-free certification, since the virus involved was vaccine-derived rather than wild.
Earlier instances have been reported as well. In 2011, a vaccine-derived virus was detected in West Bengal’s Howrah district. Another case emerged in Beed district, Maharashtra, where an 11-month-old boy with an immune disorder developed brain lesions after contracting the vaccine-derived strain and sadly passed away.
In 2021, Kerala also documented a rare transmission case: a seven-month-old baby with Severe Combined Immunodeficiency (SCID) received the oral vaccine but couldn’t clear the weakened virus from his system. The virus was later passed to his father through the fecal-oral route, as reported by The Times of India.
Vaccine-derived polio tends to appear in communities where immunization coverage is low. The weakened virus from OPV can circulate in such areas, undergo genetic changes, and, over time, transform back into a version capable of causing paralysis, the World Health Organization (WHO) explains. When this mutated strain starts spreading in the community, it’s known as a “circulating vaccine-derived poliovirus” (cVDPV).
In India, the few vaccine-derived cases reported so far have primarily been seen in children with weak immune systems, who are unable to fight off even the weakened vaccine virus. Poor sanitation and incomplete vaccination coverage further increase the risk of such mutations.
The oral polio vaccine remains highly effective at preventing the spread of the virus from person to person, and it is easy, drop-based delivery has made it the foundation of the global eradication effort. However, one drawback is that, on rare occasions, it can cause infection or transmit the weakened virus to others, as noted by the CDC.
To reduce this risk, many experts advocate switching entirely to the inactivated polio vaccine (IPV). Yet IPV has its own challenges: it requires trained medical staff for injection, which could lower immunization rates, and unlike OPV, it does not stop virus transmission through the gut.
Countries such as the United States and Canada have already moved entirely to IPV. India, however, continues to use both forms, IPV as part of routine childhood immunization and OPV for children under five during Pulse Polio campaigns.
Polio vaccination remains the best protection against both wild and vaccine-derived strains. Maintaining high IPV coverage is essential to keeping India and the rest of the world polio-free, ensuring that even rare mutations never regain a foothold.
(Credit-Canva)
COVID vaccines have often been at the center of discussions, mostly for their side effects and potential risks. But this time the spotlight is on something positive - COVID vaccine is being linked to prolonging the life of cancer patients. But not every COVID vaccine, only mRNA.
Scientists at the University of Florida and the University of Texas MD Anderson Cancer Center discovered something very important. They found that people with serious lung or skin cancer who got an mRNA COVID-19 vaccine around the time they started their anti-cancer treatment, which is immunotherapy, lived much longer than those who didn't get the shot. Specifically, the vaccine seemed helpful if it was given within 100 days of starting the cancer treatment.
Also Read: Is Bubble Tea Putting Your Health at Risk? Experts Warn About Lead Exposure
This discovery is a huge leap forward in the research to use mRNA technology—the same tech used for the COVID shots—to teach the body's natural defense system to fight cancer. It builds on previous studies and brings us closer to a potential universal cancer vaccine that could make existing cancer drugs work even better for more people.
The new study, which was written about in the journal Nature, comes from eight years of work by Dr. Sayour on mixing tiny fat bubbles with mRNA. mRNA is a natural material in your body that carries the blueprint for making proteins.
Dr. Sayour's lab previously had an unexpected finding: to make the immune system strongly attack a tumor, they didn't have to target a specific piece of the cancer. Instead, they could just boost the immune system as if it were getting ready to fight a virus. This led to an experimental mRNA shot (similar to the COVID vaccines) that, when mixed with standard cancer drugs, strongly fought tumors in mice.
This success made another team member, Dr. Adam Grippin, wonder: Could the standard COVID-19 mRNA vaccine act the same way as their experimental "nonspecific" one? To find out, the researchers looked at the medical records of patients with advanced lung and skin cancers treated between 2019 and 2023.
The Mayo Clinic explains that the mRNA vaccine gives your cells a set of instructions on how to build the harmless spike protein that is on the COVID-19 virus. The vaccine sends the mRNA into your muscle and your muscle cells or other defense cells read these instructions and start making the spike protein. This is how your body prepares to protect you from the virus. Moderna and Pfizer-BioNTech are both mRNA vaccines available in the US.
Also Read: Not All Antidepressants Affect Your Body The Same; Here’s What You Need To Know About Side Effects
These findings come from checking the medical files of over 1,000 patients. It's important to know that this is only the first look at the information. Scientists must confirm these results in a strict new study called a randomized clinical trial. If the results hold up, this study could change cancer treatment forever.
The study clearly shows how powerful mRNA medicines are. The findings also point to an unexpected benefit from the government's quick push for COVID-19 vaccines (called Operation Warp Speed), showing how that effort continues to help save American lives.
The data analysis showed that getting a COVID mRNA vaccine within 100 days of starting cancer drugs was linked to significantly longer lives. This was most true for patients whose bodies weren't expected to fight their tumors very well on their own.
For 180 advanced lung cancer patients who got the vaccine, the average survival time was nearly doubled, going from 20.6 months to 37.3 months, compared to patients who didn't get the shot. For patients with widespread skin cancer (melanoma), the average survival went up from 26.7 months to somewhere between 30 and 40 months. Importantly, getting non-mRNA shots, like the regular flu vaccine, did not change survival time.
To make sure their findings were real, the UF researchers did experiments with mice, giving them immunotherapy drugs along with an mRNA vaccine for the COVID virus. These tests showed that the combination could make cancers that usually ignored treatment suddenly shrink and stop growing.
The next necessary step is to launch a big clinical trial to confirm these findings. If they are proven true, scientists could design an even better, general-purpose vaccine to help cancer patients. For people with late-stage cancer, the extra time they gain from this kind of treatment would be priceless. Dr. Sayour believes that even a small boost in survival, like 5% or 10%, means a huge amount to these patients, especially if this treatment can work for many different kinds of cancer.
© 2024 Bennett, Coleman & Company Limited